Regenerative medicine is revolutionizing surgical practice by harnessing the body’s natural healing abilities and developing innovative therapies to repair or replace damaged tissues and organs. This session will focus on advancements in stem cell therapy, tissue engineering, and biomaterials that are transforming reconstructive and transplant surgery. Presentations are invited on clinical applications such as cartilage regeneration, wound healing, organ scaffolding, and the use of growth factors in surgical recovery. Discussions will also cover translational challenges, regulatory approvals, and ethical considerations in regenerative therapies. Researchers and clinicians are encouraged to share results from preclinical studies, clinical trials, and innovative technologies that hold promise for restoring function and improving patient outcomes. By uniting surgeons, bioengineers, and scientists, this session will highlight how regenerative medicine is moving from experimental labs into operating rooms, paving the way for a future where surgical interventions not only repair but also regenerate human tissues.